Navigation Links
ChanTest Launches Redesigned Web Site
Date:6/9/2008

CLEVELAND, June 9 /PRNewswire/ -- ChanTest, the leading provider of ion channel testing services for drug-discovery and development applications, has launched a completely redesigned Web site at http://www.ChanTest.com.

According to Dr. Arthur Brown, founder and CEO of ChanTest, the company's goal was to make the site more accessible to visitors, while providing significant improvements in content, navigation, and visual appeal. "The Internet is an important part of our strategy to meet the needs of the drug discovery and development community," said Dr. Brown. "For example, our 'Ask a Scientist' feature makes it easy, at a click of a button, to consult a ChanTest ion channel expert. We also take seriously our commitment to be a resource for members of the press and others who may be interested in learning more about the importance of ion channels in drug safety. An explanation of the cardiac safety issue can be found under 'Technology & Applications' from the main menu."

The new design structure makes it easier for users to find Web content. For example, many of the more than 300 articles by ChanTest scientists that have appeared in peer-reviewed journals can be downloaded easily by clicking on the article title. This comprehensive list of ChanTest articles can be found on the "Publications" page, accessible from "Technology & Applications" on the main menu. The site also features an extensive search function, scrolling headlines highlighting what's new, and listings of upcoming conferences and events.

About ChanTest

The preeminent ion channel services company, ChanTest serves its drug discovery and development customers with GLP safety and automated screening assays using its library of ion channel-expressing cell lines - the most comprehensive in the world. Since its inception in 1998, ChanTest has tested more than 12,000 compounds for more than 250 global pharmaceutical and biotech companies - helping them to achieve their drug safety and discovery goals. ChanTest works in partnership with customers to speed the drug-development process, save time and money, and ultimately - to help make better, safer drugs. Because of ChanTest's seminal role in this field, along with the company's uncompromising commitment to quality, ChanTest was named "most trusted fee-for-service provider" for ion channel screening in the HTStec Ion Channel Trends Survey for two years in a row. ChanTest is based in Cleveland, Ohio. For more information, please visit http://www.chantest.com


'/>"/>
SOURCE ChanTest
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. ChanTest to Highlight Expanded Ion Channel Testing Services for Preclinical Safety at ToxExpo, Including the Worlds Largest Catalog of Validated Ion Channels, Booth 2504
2. ChanTest to Highlight Most-Comprehensive Range of Ion Channel Profiling Screens and Consultation Services at 14th Annual SBS Conference, Booth 1104
3. Research Triangle Area Health Care Collaborative Launches Bridges to Excellence(R) Initiative to Improve Quality and Lower Costs
4. Novozymes Launches Enzyme to Reduce Acrylamide in Food
5. Enova Medical Launches Exos Corporation
6. Elekta Launches New Linear Accelerator at 2007 ESTRO to Expand Cancer Treatment Availability
7. Signalifes Dr. Harmison Launches Award-Winning Ambulatory Heart Monitor
8. ThirdBiotech Networking Group Launches
9. BioReliance Launches Next-Generation Genotoxicity Screening Service
10. Midwest Research Institute Launches Center for Biological Safety and Security (CBS2)
11. BioReliance Corporation Launches iNet(TM) for Online Results Tracking of Biological Safety Tests
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... Colo. , March 23, 2017  Agriculture technology ... Series A financing and note conversion to commercialize its ... Planet is focused on developing products that are simultaneously ... $30 million in the last 18 months. This latest ... North Bridge Venture Partners. The company,s ...
(Date:3/22/2017)... ... March 22, 2017 , ... ... tissue regeneration from small lab samples to full-size tissues, bones, even whole organs ... a vascular system that delivers blood deep into the developing tissue. , ...
(Date:3/22/2017)... 2017 Oramed Pharmaceuticals Inc. (NASDAQ: ... ), a clinical-stage pharmaceutical company focused ... announced today that Dr. Miriam Kidron , ... titled, "Oral Insulin for Diabetes Treatment: Bypassing the ... and Peptide Therapeutics (OPT) Boston Conference in ...
(Date:3/22/2017)... March 22, 2017 /PRNewswire/ - FACIT announced a ... or "Propellon"), a start-up created by FACIT focused ... FACIT,s investment, combined with non-dilutive capital, achieves a ... seed funding enables Propellon to accelerate the nomination ... for financing and/or entering a strategic partnership for ...
Breaking Biology Technology:
(Date:3/2/2017)... 2, 2017 Summary This report ... Merck KGaA and its partnering interests and activities since ... Description The Partnering Deals and Alliance since 2010 ... of one of the world,s leading life sciences companies. ... purchase to ensure inclusion of the most up to ...
(Date:2/28/2017)... News solutions for biometrics, bag drop and ... ... to 16 March, Materna will present its complete end-to-end passenger ... is a real benefit for passengers. To accelerate the whole ... touch point solutions to take passengers through the complete integrated ...
(Date:2/22/2017)... , Feb. 22, 2017 With the ... ABI Research identifies four technologies that innovative and ... secure significant share in the changing competitive landscape: ... passive authentication.   "Companies can no ... to security," says Dimitrios Pavlakis , Industry ...
Breaking Biology News(10 mins):